Chris Hadfield

Chris Hadfield appears in 2 stories from the Canadian Securities Exchange since 2014.

May 4, 2020#HashtagFinance

Chris Moreau on How Science Fiction Has Inspired a Potentially Lung-Saving Therapy

CSE’s Barrington Miller was recently joined by Christopher Moreau, CEO of Algernon Pharmaceuticals Inc. (CSE:AGN), to discuss his company’s work to develop NP-120 (Ifenprodil) as a new therapeutic in the fight against COVID-19. In this discussion, Chris outlines how his company focuses on drug re-purposing, a term that is widely understood through the example provided…

Jan 21, 2014Events

Our day at the Cantech Investment Conference in Toronto

CSE had the pleasure of attending and exhibiting at the 2014 Cantech Conference in Toronto on January 16th. This is the first such show from Cambridge House International who have traditionally organized mining conferences including the Vancouver and World Resource Investment Conferences. Some highlights from our day at Cantech: Discussions centred around how to fund,…